NDA’s breakfast seminar is back by popular demand

Join us to hear Paul Chamberlain, Biopharmaceuticals & Immunogenicity Expert at NDAs Advisory Board, speak on anticipating and avoiding issues for biopharmaceutical development.

Detaljer

Börjar: 29 May @ 09:00

Slutar: 29 May @ 10:00

Webbplats: Klicka här

Arrangör

Värd: NDA Group

Plats

SciLifeLab (Air & Fire at ground floor),Tomtebodavägen 23, Solna, Sverige

Join us to hear Paul Chamberlain, Biopharmaceuticals & Immunogenicity Expert at NDAs Advisory Board, speak on anticipating and avoiding issues for biopharmaceutical development.

Learning aspects:

  • How to apply immunogenicity risk assessment at the lead candidate selection stage
  • Minimizing incremental risks associated with manufacturing
  • Understanding what and how to evaluate, at different stages of clinical development
  • Integrated presentation of data to regulatory agencies

Registration: RSVP by Thursday 17th May 2018 to: frukostseminarium@ndareg.com

The breakfast seminar will be an open and interactive workshop with the opportunity to ask questions to Paul. Specific questions can also be sent in advance to frukostseminarium@ndareg.com Indicate if you would like to discuss them openly during the meeting; otherwise we can book separate meetings to discuss them after the seminar. Contact: Lina Jansson, Marketing Associate, +46 (0)8 590 778 00, or email frukostseminarium@ndareg.com

Breakfast from 8:30am

The breakfast seminar is free. If you are unable to attend, please advise us no later than two days before the seminar.